Product Images Levetiracetam

This text provides a formula to calculate the total daily dose in mL for a patient based on their weight and the daily dose in mg/kg/day. The concentration of the medication is stated to be 100 mg/mL.*

This appears to be a formula or equation for estimating renal clearance (CLer) in patients based on age, weight, and serum creatinine levels. The formula involves subtracting the patient's age from 140, multiplying that by their weight in kilograms, then dividing by 72 times their serum creatinine level. This value is then adjusted for body surface area (BSA) using a conversion factor of 1.73. The formula includes a separate calculation for females.*

This appears to be a table showing the percentages of patients in different treatment groups (placebo, levetiracetam 1000 myjday, levetiracetam 2000 myjday) for a medical study. The percentages represent different outcomes for patients, but without further information on the study, it is not possible to determine what these outcomes are.*

This is a table showing the percentage of patients who participated in a study, with Placebo and Levetiracetam groups represented. However, without context or additional information, it is difficult to determine what the percentages represent.*

This is a description of the percentage of patients who participated in a clinical trial and received either a placebo (a non-active substance) or levetiracetam (a medication used to treat seizures and epilepsy). Of the 51 patients who received the placebo, 19.6% showed some sort of positive response or improvement. In comparison, of the 58 patients who received levetiracetam, a higher percentage of 43.1% responded positively. This information is likely being presented to show the effectiveness of levetiracetam over a placebo in treating the condition being studied.*

The text represents a chart that compares the percentage of patients under placebo (N=84) and levetiracetam (N=79) treatment. The percentages represent values of efficacy or response rate, as shown by the title "% of Patients".*

This is a description of a medication called Levetiracetam in the form of tablets. The package contains 500 coated tablets with each tablet containing USP 250m. The recommended dosage can be found in the package insert. Pharmacists are advised to dispense the medication in a container that is resistant to light and moisture and store it at 25°C. The accompanying Medication Guide is required to be received by the patient. The text also includes a NDC number and manufacturer information, Lupin Limited.*

Levetiracetam Tablets USP with NDC code 68180-11202 are prescription drugs dispensed by a pharmacist. Each tablet contains 250mg of Levetiracetam, and the usual dosage can be found on the package insert. The medication guide should be provided separately, and storage should be at 25°C. The tablets come in a container that is resistant to light and moisture. If the text on the package is legible, it is produced by Lupin Limited. If not, the manufacturer's name is not available.*

Levetiracetam is a medication available in the form of fin-cosed tablets with a strength of 500 tablets to be dispensed with prescription only. Usual Dosage: Refer to the packaging for dosage recommendations. It is advised to store the medication at a temperature between 25°C to 30°C. The rest of the text is not readable.*

Levetiracetam is a prescription drug sold in the form of tablets under the brand LUPIN. It is available in a 500-tablet package with each film-coated tablet containing 500mg of Levetiracetam USP. It is recommended to store at a temperature not exceeding 25° Celsius or 77 degrees Fahrenheit. The manufacturer of the drug is Lupin Pharmaceuticals Inc. based in Baltimore, Maryland. A medication guide is provided, and the pharmacist should receive a prescription before dispensing the drug.*

This is a medication description for Levetiracetam Tablets USP, with a National Drug Code of 68180-114-02. There are dosing instructions, but the rest of the text is not available or is difficult to read due to errors in .*

Levetiracetam is a medication available in tablet form with 1000mg of the active ingredient. The usual dosage is provided in the package insert. Medication guide must accompany this medication, dispensed in a container resistant to light. Store between 15-30°C. Manufactured by Lupin Limited in India for Lupin Pharmaceuticals in Maryland.*

This is a description of a medication named Levetiracetam that is in tablet form with a strength of 1000mg. The medication is made by Lupin Pharmaceuticals and comes with an accompanying medication guide. The recommended storage temperature is between 15 to 30°C. This medication is only available with a prescription from a licensed healthcare professional. The package includes 500 tablets.*